Company Filing History:
Years Active: 2006-2019
Title: Jacek Stalewski: Innovator in Pharmaceutical Chemistry
Introduction
Jacek Stalewski is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical chemistry. With a total of 5 patents, his work primarily focuses on developing compounds that address critical health issues, including hypertension and related conditions.
Latest Patents
Stalewski's latest patents include innovative compounds such as angiotensin-1-receptor antagonists. These compounds, described by the formula (I), are designed to treat hypertension, particularly hypertension induced by pregnancy, preeclampsia, or renal diseases associated with pregnancy. Additionally, he has developed methods for synthesizing intermediates and oxytocin analogues, providing more efficient and economical approaches to creating heptapeptide alcohol analogs of oxytocin.
Career Highlights
Throughout his career, Jacek Stalewski has worked with prominent companies in the pharmaceutical industry, including Ferring B.V. and Cara Therapeutics, Inc. His expertise in pharmaceutical chemistry has allowed him to contribute to the development of vital therapeutic solutions.
Collaborations
Stalewski has collaborated with esteemed colleagues such as Kazimierz Wisniewski and Guangcheng Jiang, further enhancing the impact of his work in the field.
Conclusion
Jacek Stalewski's innovative contributions to pharmaceutical chemistry, particularly in the development of compounds for treating hypertension, highlight his role as a significant inventor in the industry. His work continues to influence the advancement of medical treatments and improve patient outcomes.